Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)-infected patients.

Kaja ScheibeAnna UrbańskaPaweł JakubowskiMaria HlebowiczMonika Bociąga-JasikAleksandra RaczyńskaAleksandra SzymczakBartosz SzetelaWładysław ŁojewskiMiłosz Parczewski

Published in: Antiviral therapy (2021)

The frequency of transmitted drug resistance to DOR is low, allowing for effective treatment of antiretroviral treatment-naïve patients and rapid treatment initiation. In cART-experienced patients, this agent remains an attractive NNRTI option with a higher genetic barrier to resistance.

Keyphrases

hiv infected patients
end stage renal disease
ejection fraction
newly diagnosed
endothelial cells
peritoneal dialysis
gene expression
risk factors
hiv infected
genome wide